Literature DB >> 8813989

Riluzole.

J Wokke1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8813989     DOI： 10.1016/S0140-6736(96)03181-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  27 in total

1.  Human skeletal muscle stem cell antiinflammatory activity ameliorates clinical outcome in amyotrophic lateral sclerosis models.

Authors:  Laura Canzi; Valeria Castellaneta; Stefania Navone; Sara Nava; Marta Dossena; Ileana Zucca; Tiziana Mennini; Paolo Bigini; Eugenio A Parati
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 2.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 3.  Health outcome and quality-of-life measurements in amyotrophic lateral sclerosis.

Authors:  M Swash
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

4.  Is glutamate involved in transient lower esophageal sphincter relaxations?

Authors:  D P Hirsch; G N J Tytgat; G E E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

5.  Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.

Authors:  Cecilia L Speyer; Miriam A Bukhsh; Waris S Jafry; Rachael E Sexton; Sudeshna Bandyopadhyay; David H Gorski
Journal:  Breast Cancer Res Treat       Date:  2017-08-05       Impact factor: 4.872

Review 6.  Spinal muscular atrophy.

Authors:  Susan T Iannaccone; Stephen A Smith; Louise R Simard
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

7.  Riluzole is a promising pharmacological inhibitor of bilirubin-induced excitotoxicity in the ventral cochlear nucleus.

Authors:  Guo-Ying Han; Chun-Yan Li; Hai-Bo Shi; Ji-Ping Wang; Kai-Ming Su; Xin-Lu Yin; Shan-Kai Yin
Journal:  CNS Neurosci Ther       Date:  2014-12-12       Impact factor: 5.243

Review 8.  Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.

Authors:  Joshua Kuruvilla; Andrew Octavian Sasmita; Anna Pick Kiong Ling
Journal:  Neurol Sci       Date:  2018-08-03       Impact factor: 3.307

9.  Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.

Authors:  H J M van Kan; G J Groeneveld; S Kalmijn; M Spieksma; L H van den Berg; H J Guchelaar
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

10.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.